Click Therapeutics
PrivateLast Round
Series D
Apr 9, 2026
Est. Valuation
$312.53M
Total Funding Raised
$302.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Click Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series D round in April 2026.
Click Therapeutics is a healthcare company that develops and commercializes software as prescription medical treatments for patients with unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Clinical Trials, Mental Health
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Click Therapeutics Comparables
Compare Click Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Big Health | 81% | |
| Sidekick Health | 79% | |
| Virtual Therapeutics | 78% |
For institutional investors. Book with your work email.
Click Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Apr 9, 2026 | ||||
| Series C | Mar 19, 2025 | ||||
| Growth Equity | Apr 3, 2024 | ||||
| Debt | Nov 6, 2023 | ||||
| Debt | Apr 15, 2022 | ||||
Series B | Oct 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Click Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Growth Equity, Series D |
| HIG BioHealth Partners | Series B |
| Health Catalyst Capital Management | Series B |
| Dassault Systèmes | Series C |
| Supernode Ventures | Seed, Series A |
| Sanofi Ventures | Series B, Series A |
| Revelation Partners | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 51% MoM.
- Apr 17, 2026
25 employees laid off, representing over 25% of the team.
For institutional investors. Book with your work email.
Click Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Click Therapeutics's valuation, stock price, and market status.
Is Click Therapeutics a public or private company?
Click Therapeutics is a private company.
What is the current stock price of Click Therapeutics?
Click Therapeutics is a private company, so its shares have no public market price. Caplight tracks Click Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Click Therapeutics worth (valuation)?
Click Therapeutics's valuation is estimated at $312.5M based on funding round data.
Can I buy Click Therapeutics stock?
Click Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Click Therapeutics's last funding round?
Click Therapeutics's most recent funding round was Series D on April 9, 2026.
Who are the main investors in Click Therapeutics?
Key investors in Click Therapeutics include Boehringer Ingelheim, HIG BioHealth Partners, Sanofi Ventures, Accelmed, HSBC Innovation Banking.
Will Click Therapeutics IPO soon?
No public IPO plans have been announced for Click Therapeutics.
How can I track Click Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Click Therapeutics's shares on secondary markets.